Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Liver Int. 2012 Oct 29;33(1):72–78. doi: 10.1111/liv.12013

Fig 2. Patient survival according to Il-28B genotype.

Fig 2

Panel A. Kaplan-Meier curves for the recipient IL28B genotypes. The estimated hazard ratio for recipient Non-CC: CC, adjusted for donor IL28B genotype was 1.12 (95% CI 0.59–2.11)), P=0.73. Panel B Kaplan-Meier curves for the donor IL28B genotypes. The estimated hazard ratio for donor Non-CC: CC, adjusted for recipient IL28B genotype was 1.30 (95% CI 0.70–2.41), P=0.41.